Therapeutic Solutions International, Inc.
TSOI · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $99 | $207 | $146 | $63 |
| % Growth | -52.1% | 41.7% | 132.9% | – |
| Cost of Goods Sold | $37 | $79 | $43 | $13 |
| Gross Profit | $62 | $127 | $103 | $50 |
| % Margin | 62.9% | 61.6% | 70.9% | 79.6% |
| R&D Expenses | $561 | $1,441 | $795 | $562 |
| G&A Expenses | $1,055 | $1,766 | $1,613 | $1,337 |
| SG&A Expenses | $1,488 | $1,766 | $1,613 | $1,337 |
| Sales & Mktg Exp. | $433 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,049 | $3,207 | $2,408 | $1,899 |
| Operating Income | -$1,986 | -$3,279 | -$2,304 | -$1,850 |
| % Margin | -2,006.7% | -1,586% | -1,578.8% | -2,950.8% |
| Other Income/Exp. Net | -$236 | -$597 | -$656 | -$350 |
| Pre-Tax Income | -$2,222 | -$3,876 | -$2,961 | -$2,200 |
| Tax Expense | $2 | $2 | $1 | $0 |
| Net Income | -$2,170 | -$3,814 | -$2,961 | -$2,200 |
| % Margin | -2,191.9% | -1,844.6% | -2,029% | -3,509.7% |
| EPS | -0.001 | -0.002 | -0.001 | -0.001 |
| % Growth | 53.3% | -15.4% | -8.3% | – |
| EPS Diluted | -0.001 | -0.002 | -0.001 | -0.001 |
| Weighted Avg Shares Out | 3,168,901 | 2,528,063 | 2,263,127 | 1,911,855 |
| Weighted Avg Shares Out Dil | 3,168,901 | 2,528,063 | 2,263,127 | 1,911,855 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $423 | $646 | $612 | $302 |
| Depreciation & Amortization | $312 | $245 | $18 | $7 |
| EBITDA | -$1,487 | -$2,986 | -$2,331 | -$1,890 |
| % Margin | -1,502.5% | -1,444% | -1,596.9% | -3,016% |